Clinical Trials Logo

Urinary Incontinence, Urge clinical trials

View clinical trials related to Urinary Incontinence, Urge.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT05381116 Terminated - Overactive Bladder Clinical Trials

A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder

REDUCEOAB
Start date: April 14, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, sham-controlled study comparing the safety and effectiveness of the self-adjusting, surgery-free, wearable Active System to a Sham System on adult Subjects diagnosed with OAB.

NCT ID: NCT04059653 Terminated - Clinical trials for Urinary Incontinence

Evaluation of a New Technology for the Treatment of Bladder Leakage in Women

Start date: January 6, 2020
Phase: N/A
Study type: Interventional

Evaluation of a new technology for the treatment of bladder leakage in women. The objective is to compare quality of life and other incontinence associated outcomes between women receiving routine General Practitioner (GP) prescribed care for urinary incontinence compared with those prescribed the electrical stimulation device.

NCT ID: NCT03923348 Terminated - Overactive Bladder Clinical Trials

Pelvic Floor Muscle Training With Leva System for Urge Incontinence

Start date: June 6, 2019
Phase: N/A
Study type: Interventional

This is a pilot non-comparative study to assess the effectiveness of pelvic floor muscle training guided by the leva® system for improving change in subject-reported incontinence-related quality of life and urgency urinary incontinence (UUI) episode frequency based on voiding diaries in women at 8 weeks.

NCT ID: NCT03687164 Terminated - Overactive Bladder Clinical Trials

Group Medical Visits for Latina Women With Urgency Urinary Incontinence

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

This is a mixed methods study to compare group medical visits (GMVs) to usual care for Spanish speaking Latina women with urgency urinary incontinence. Patients will be randomized to GMVs and to usual care. At the conclusion of each series of GMVs we will hold a focus group for participants.The primary outcome will be improvement in urgency urinary incontinence symptoms.

NCT ID: NCT02922842 Terminated - Overactive Bladder Clinical Trials

A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder

Start date: July 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to compare patient centered- outcomes between Transcutaneous Electrical Nerve Stimulation (TENS) at three locations to treat urinary urge incontinence. One of these locations will be along the tibial nerve, which is traditionally accessed near the medial malleolus. The second site will be on the sacral nerve which is accessed over the sacrum. The third site will be a sham site on the shoulder. This study will evaluate the feasibility of transcutaneous electrical stimulation in the treatment of overactive bladder.

NCT ID: NCT02781636 Terminated - Urge Incontinence Clinical Trials

Protect Chronic Tibial Nerve Stimulator (CTNS) System

Start date: April 2016
Phase: N/A
Study type: Interventional

30 patient Study. All patients implanted with StimGuard Protect System. Patient followed out to 90 days.

NCT ID: NCT02776475 Terminated - Clinical trials for Urinary Urge Incontinence

The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence

Start date: August 4, 2016
Phase: N/A
Study type: Interventional

This prospective one group cohort study seeks to investigate the effects of sacral neuromodulation on urinary urgency, frequency and urge incontinence are maintained after the simulator device is temporarily turned off for a period of four weeks.

NCT ID: NCT02505607 Terminated - Clinical trials for Urinary Bladder, Overactive

Overactive Bladder Education

Start date: July 2015
Phase: N/A
Study type: Interventional

Overactive bladder (OAB) is a common, chronic condition, characterized by urinary "urgency, with or without urge incontinence, usually with frequency and nocturia." Treatment adherence is a major barrier to management of OAB and drug continuation is poor. Many factors may play a role in non-adherence to medication management of OAB including drug cost, side effects, and a lack of understanding of the disease and treatment process.Studies show that recall of disease information and treatment is often suboptimal. Literature shows that providing written materials is an efficacious way to aid in recall. Based on known poor adherence to OAB medication treatment and the clear role patient education methods have on patient information recall, the investigators believe that improvement of participant education through use of a OAB care plan will improve participant understanding and treatment adherence. Through this randomized trial, the investigators plan to evaluate whether implementation of a OAB Care Plan improves understanding of disease and treatment options, treatment success, and satisfaction. This is a prospective, randomized, controlled study of OAB counseling in new patients presenting to the Urogynecology offices of Hartford Hospital. All new patients with a diagnosis of OAB will be offered participation. All consenting participants will be randomized 1:1 to one of two groups: 1) Standard Care group or 2) Care Plan group. In the Standard Care group, participants will be counseled as the physician routinely counsels patients about OAB, in the Care Plan group, participants will be counseled a printed "Overactive Bladder Plan of Care" information sheet. At the end of the visit, the participant will complete a Baseline Survey. The Baseline Survey includes basic demographic information, a physician satisfaction survey, and a OAB knowledge survey. The participant will return for follow up as directed by the physician. At the follow up visit, participants in both groups will complete a Followup Survey. The Followup Survey will be completed before the participant sees the physician. The Followup Survey assesses OAB knowledge. Eight months after the baseline visit, each participant's chart will be reviewed for final data collection. If a participant progresses to a treatment method where she is satisfied and would like to remain, this will be documented.

NCT ID: NCT02176642 Terminated - Clinical trials for Urinary Urge Incontinence

Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.

APP
Start date: August 2014
Phase: Phase 4
Study type: Interventional

This is a randomized double-blind placebo-controlled clinical trial of posterior tibial nerve stimulation (PTNS) plus extended release oxybutynin versus PTNS alone (placebo pills) in women undergoing treatment of urgency urinary incontinence (UUI). The investigators hypothesize that combination therapy with PTNS and anticholinergic medication will result in a significant incremental improvement in UUI symptoms over that achieved with PTNS alone. In addition, the investigators hypothesize that the addition of anticholinergics to PTNS will result in a greater improvement in patients' perception of treatment response, symptom distress, and quality of life than PTNS alone. Specific Aim 1: To compare the change, from baseline, in mean number of UUI episodes per day using a 3-day bladder diary between PTNS plus anticholinergic medication versus PTNS plus placebo in women undergoing treatment for UUI. Specific Aim 2: To compare the change, from baseline, in a 24hr pad weight between PTNS plus anticholinergic medication versus PTNS plus placebo. Specific Aim 3: To compare subjective treatment response, symptoms distress, and quality of life between PTNS plus anticholinergic medication versus PTNS plus placebo utilizing the Patient Global Impression of Improvement (PGI-I) and the Overactive Bladder Questionnaire Short Form (OABq-SF). An interim analysis will be conducted by an independent entity after 50 participants have completed the study protocol. A Data Safety Monitoring Board is not utilized because the study utilizes FDA approved treatments for urgency urinary incontinence.

NCT ID: NCT02129816 Terminated - Overactive Bladder Clinical Trials

Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder

BryoSoliP
Start date: May 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Overactive bladder (OAB) is an enigmatic condition that is treated symptomatically with anticholinergic drugs (gold standard 2013). In a clinical pilot study was found to be a trend for a higher reduction of the micturition frequency in the Bryophyllum pinnatum group - treated with chewing tablets containing 50% of dried BP leaf press juice - than in the placebo group (n=20, p=0.064) Hypothesis: To test the superior effectivity of Bryophyllum versus Placebo in the treatment of OAB with the needed number (Purpose 1) and to assess in an experimental arm the side effects of BP in comparison to the standard drug (Vesicare) in a clincial trial (Purpose 2).